1. Home
  2. NEO vs BHE Comparison

NEO vs BHE Comparison

Compare NEO & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • BHE
  • Stock Information
  • Founded
  • NEO 2001
  • BHE 1979
  • Country
  • NEO United States
  • BHE United States
  • Employees
  • NEO N/A
  • BHE N/A
  • Industry
  • NEO Precision Instruments
  • BHE Electrical Products
  • Sector
  • NEO Health Care
  • BHE Technology
  • Exchange
  • NEO Nasdaq
  • BHE Nasdaq
  • Market Cap
  • NEO 1.2B
  • BHE 1.3B
  • IPO Year
  • NEO 1999
  • BHE 1990
  • Fundamental
  • Price
  • NEO $8.04
  • BHE $35.00
  • Analyst Decision
  • NEO Buy
  • BHE Strong Buy
  • Analyst Count
  • NEO 9
  • BHE 2
  • Target Price
  • NEO $13.31
  • BHE $47.00
  • AVG Volume (30 Days)
  • NEO 3.1M
  • BHE 318.7K
  • Earning Date
  • NEO 04-29-2025
  • BHE 04-29-2025
  • Dividend Yield
  • NEO N/A
  • BHE 1.91%
  • EPS Growth
  • NEO N/A
  • BHE N/A
  • EPS
  • NEO N/A
  • BHE 1.44
  • Revenue
  • NEO $672,361,000.00
  • BHE $2,612,294,000.00
  • Revenue This Year
  • NEO $13.05
  • BHE $4.55
  • Revenue Next Year
  • NEO $11.18
  • BHE $7.17
  • P/E Ratio
  • NEO N/A
  • BHE $24.70
  • Revenue Growth
  • NEO 10.10
  • BHE N/A
  • 52 Week Low
  • NEO $6.08
  • BHE $30.73
  • 52 Week High
  • NEO $19.11
  • BHE $52.57
  • Technical
  • Relative Strength Index (RSI)
  • NEO 43.86
  • BHE 47.21
  • Support Level
  • NEO $7.66
  • BHE $33.69
  • Resistance Level
  • NEO $8.31
  • BHE $35.73
  • Average True Range (ATR)
  • NEO 0.76
  • BHE 1.18
  • MACD
  • NEO -0.01
  • BHE 0.04
  • Stochastic Oscillator
  • NEO 45.94
  • BHE 51.68

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and advanced manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.

Share on Social Networks: